Enroll now in Champions' new Sarcoma In Vivo Screen including 40 unique PDX models that are well characterized with patient treatments, clinical annotation, and include NGS (WES and RNA-seq) and Proteomics data, available in Lumin.

This unique set of Sarcoma models includes several subtypes, including rare forms such as GIST, synovial sarcoma, and DSRCT, as well as represent a variety of treatments and clinically relevant genetic mutations.

Sarcoma In Vivo Screen highlights:

• 40 unique Sarcoma PDX models 
• Increased cost saving compared to standalone studies
• 50% off of a Standard of Care agent arm (selected by Champions)
• No minimum number of models to enroll and you have the ability to select the models you want to screen
• Flow Cytometry and IHC are available upon request.
• Terminal tumor collections (Snap Frozen/FFPE) for target validation available upon request.
• Full model characterization (clinical data and NGS) is available for data analysis and visualization using Lumin